Why is Amerise BioScie falling/rising?
As of 24-Sep, Amerise Biosciences Ltd is priced at Rs. 0.66, reflecting a downward trend with a 52-week low and significant declines of 10.81% over the past week and 45.45% year-to-date, despite increased investor interest. The stock's performance starkly contrasts with the benchmark Sensex, which has gained 4.58% year-to-date.
As of 24-Sep, Amerise Biosciences Ltd is currently priced at Rs. 0.66, showing no change (0.00%). The stock has hit a new 52-week low today, indicating a downward trend. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a persistent decline in its price. Over the past week, the stock has decreased by 10.81%, and it has seen a significant drop of 45.45% year-to-date. However, there has been a notable increase in investor participation, with delivery volume rising by 828.18% against the 5-day average, indicating some interest despite the overall negative performance. There are no positive or negative factors available to further explain the stock's recent movement.Broader market context shows that while Amerise Biosciences has been declining, the benchmark Sensex has only fallen by 1.18% over the past week and has gained 4.58% year-to-date. This stark contrast highlights the underperformance of Amerise compared to the broader market. The stock's significant losses over various periods, including a 14.29% drop in the last month and a 34.65% decline over three years, further emphasize its struggles relative to the benchmark's positive returns.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
